Home › Funds › SILVERARC CAPITAL MANAGEMENT, LLC › IMNM
SILVERARC CAPITAL MANAGEMENT, LLC position in IMNM
IMMUNOME INC · Health Care
SILVERARC CAPITAL MANAGEMENT, LLC reported holding 2,092,715 shares of IMNM (IMMUNOME INC) in its Q3 2026 13F filing — a position valued at US$45.0M, representing 5.74% of its reported portfolio and ranking #5 among its reported holdings. SILVERARC CAPITAL MANAGEMENT, LLC has disclosed IMNM holdings in 5 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How SILVERARC CAPITAL MANAGEMENT, LLC's IMNM position evolved
SILVERARC CAPITAL MANAGEMENT, LLC first disclosed a stake in IMNM in Q1 2024 at 7,489 shares (US$185K). The position peaked in Q3 2026 at 2,092,715 shares, worth US$45.0M. Across 5 filings, SILVERARC CAPITAL MANAGEMENT, LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,092,715 shares valued at US$45.0M — an increase of 75,706 shares quarter over quarter.. Notable position changes include a 64% increase in Q1 2026 (shares fell 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 7.49K | $184.83K | New |
| Q4 2025 | 1.13M | $24.19M | New |
| Q1 2026 | 1.85M | $40.47M | Add |
| Q2 2026 | 2.02M | $42.74M | Add |
| Q3 2026 | 2.09M | $45.01M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMNM and 13F data
IMNM (IMMUNOME INC) is a Health Care company. 42 other funds we track also report a position in IMNM — the largest reported positions include Redmile Group, LLC (US$104.1M), Enavate Sciences GP, LLC (US$76.6M), Sofinnova Investments, Inc. (US$36.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMNM
- Redmile Group, LLC 4.91M sh · $104.08M · Q2 2026
- Enavate Sciences GP, LLC 3.61M sh · $76.58M · Q2 2026
- Sofinnova Investments, Inc. 1.72M sh · $36.45M · Q2 2026
- READYSTATE ASSET MANAGEMENT LP 1.61M sh · $34.03M · Q2 2026
- Pivotal bioVenture Partners Investment Advisor LLC 732.51K sh · $15.52M · Q2 2026
- NAN FUNG TRINITY (HK) Ltd 621.08K sh · $13.36M · Q3 2026
- Parkman Healthcare Partners LLC 594.20K sh · $12.59M · Q2 2026
More on SILVERARC CAPITAL MANAGEMENT, LLC
FAQ
How long has SILVERARC CAPITAL MANAGEMENT, LLC held IMNM?
SILVERARC CAPITAL MANAGEMENT, LLC has disclosed IMNM holdings in 5 of the last 11 reported quarters, going back to Q1 2024.
What is SILVERARC CAPITAL MANAGEMENT, LLC's current position in IMNM?
As of Q3 2026, SILVERARC CAPITAL MANAGEMENT, LLC holds 2.09M shares of IMNM (IMMUNOME INC), valued at $45.01M, representing 5.74% of its reported portfolio and ranking #5.
Has SILVERARC CAPITAL MANAGEMENT, LLC been buying or selling IMNM?
In the latest 13F filing (Q3 2026), SILVERARC CAPITAL MANAGEMENT, LLC increased its position in IMNM. The position peaked in Q3 2026 at 2.09M shares.
Which other funds hold IMNM?
Other major institutional holders of IMNM include Redmile Group, LLC, Enavate Sciences GP, LLC, Sofinnova Investments, Inc., among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.